Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2020-11-03 M&A Activity
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(렌질루맙(Lezilumab, COVID-19 치료제)의 한국 및 필리핀 라이선스 도입 계약 체결)
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Telcon RF Pharmaceutical) announcing a material business event, specifically a licensing agreement for a COVID-19 treatment (Lenzilumab). This type of disclosure regarding significant business contracts, partnerships, or licensing deals is classified as a general regulatory filing (RNS) in the absence of a more specific category like M&A or capital raising.
2020-11-03 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing titled '정정신고(보고)' (Correction Report) regarding a '전환사채권 발행결정' (Decision to Issue Convertible Bonds). It details specific changes to the use of proceeds and other terms of a previously announced convertible bond issuance. This is a standard corporate disclosure document filed with the Korea Exchange (KRX) regarding capital structure and financing activities. It fits the 'Capital/Financing Update' category as it provides specific details on the issuance of debt instruments (convertible bonds) and updates to their terms.
2020-10-16 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement regarding the issuance of convertible bonds (전환사채). It details the issuance amount, payment date, and method. This falls under the category of company fundraising and financing activities, which corresponds to the 'CAP' (Capital/Financing Update) classification.
2020-10-16 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a formal 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange. It details the decision to issue convertible bonds (전환사채권 발행결정), including terms, interest rates, conversion prices, and use of proceeds. This type of filing is a standard regulatory disclosure for capital raising activities in the Korean market, which falls under the 'Capital/Financing Update' category.
2020-09-28 Korean
[기재정정]투자판단관련주요경영사항(SCD API(겸상적혈구질환 치료제 원료의약품)의 독점공급권 계약 체결)
Legal Proceedings Report Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically titled 'Investment Judgment Related Major Management Matters' (투자판단 관련 주요경영사항). It details a correction to a previous disclosure regarding a supply agreement and collateral arrangements for convertible bonds. Since it is a formal regulatory announcement of a material corporate event that does not fit into specific categories like M&A or Earnings, it is classified as a general Regulatory Filing (RNS).
2020-09-28 Korean
[기재정정]주요사항보고서(중요한자산양수도결정(기타))
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Services Commission. It details a significant asset acquisition (SCD API supply rights) and includes an external valuation report. While it contains financial data and management explanations, it is a formal regulatory filing regarding a specific corporate event (asset acquisition/disposal), which falls under the 'Regulatory Filings' category as it is a standard disclosure document in the Korean market.
2020-09-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.